Disclosed is an antibody composition comprising at least two distinct anti-human EGFR antibodies: (a) said first distinct anti-EGFR antibody is an antibody comprising the CDR1, CDR2, and CDR3 of the heavy chain SEQ ID NO: 40 and CDR1, CDR2, and CDR3 of the light chain SEQ ID NO: 72 of antibody 992; and (b) said second distinct anti-EGFR antibody is an antibody comprising the CDR1, CDR2, and CDR3 of the heavy chain SEQ ID NO: 41 and CDR1, CDR2, and CDR3 of the light chain SEQ ID NO: 73 of antibody 1024.